Clinical Trial Update: A Study of Brenipatide in Adult Participants With Major Depressive Disorder [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Brenipatide for major depressive disorder is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Brenipatide

Snippet

Sponsor: Eli Lilly and Company | Conditions: Depressive Disorder, Major | Phase 3 | Status: RECRUITING